Meeting
2023 ASCO Gastrointestinal Cancers Symposium
Predictive biomarkers for response to immunotherapy in patients with deficient DNA mismatch repair metastatic colorectal cancer.
Authors
Amos Stemmer
Institute of Oncology, Sheba Medical Center, Ramat Gan, Israel;
Amos Stemmer , Gal Strauss , Naama Halpern , Tamar Beller , Talya Golan , Ofer Margalit , Einat Shacham-Shmueli , Ben Boursi
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Other
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 254)
DOI
10.1200/JCO.2023.41.4_suppl.254
Abstract #
254
Poster Bd #
N16
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Impact of WNT/B-catenin alterations and metastasis location among patients with metastatic colorectal cancer (mCRC) treated with immune checkpoint inhibitors (ICI) combinations.
First Author: Javier Ros Montañá
Poster
2023 ASCO Annual Meeting
The study of immune-related adverse events in a community-based centre.
First Author: Sandhya Cautha
Poster
2022 ASCO Annual Meeting
The effect of the microbiome on immune checkpoint inhibitor toxicity in patients with melanoma.
First Author: Nyelia Williams
Poster
2022 ASCO Annual Meeting
A retrospective study of ipilimumab plus nivolumab in anti–PD-L1/PD-1-refractory merkel cell carcinoma.
First Author: Sophia Z. Shalhout